Investment
Features
FeesSafety
Academy
More
Pluang+

Compare ProShares UltraPro Short QQQ ETF (SQQQ) vs UnitedHealth Group Inc (UNH) Price & Performance

ProShares UltraPro Short QQQ ETFTrade
UnitedHealth Group IncTrade

Price performance (Past 24H)

Key statistics

ProShares UltraPro Short QQQ ETF vs UnitedHealth Group Inc — how do they compare? ProShares UltraPro Short QQQ ETF trades at $32.95 (market cap $2.23B), while UnitedHealth Group Inc trades at $379.3 (market cap $332.96B). The key difference: UnitedHealth Group Inc is far larger — about 149.3× ProShares UltraPro Short QQQ ETF's market cap, and UnitedHealth Group Inc pays a 2.5% dividend while ProShares UltraPro Short QQQ ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold ProShares UltraPro Short QQQ ETF for 12 Days and UnitedHealth Group Inc for 97 Days on average.

SQQQUNH
Market Cap
$2.23B$332.96B
Volume
60,436,0127,273,749
Sector
Leveraged / InverseHealth
52-Week High
$89.43$436.35
52-Week Low
$31.83$259.02
Typical Hold Time
12 Days97 Days
Enterprise Value
—$374.82B
Dividend Yield
—2.5%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

ProShares UltraPro Short QQQ ETF

SQQQ trades at $32.95, up 2.71% with a bearish technical signal from moving averages while oscillators remain neutral. The ETF shows no traditional financial ratios as it's an inverse leveraged product designed to move opposite the Nasdaq 100. Recent news highlights its role as a hedging tool against tech sector declines, with articles discussing strategic pairing with QQQ positions.

As a 3x leveraged inverse ETF, SQQQ carries significant risk from daily rebalancing and decay. It serves as a tactical tool for bearish Nasdaq 100 views or portfolio hedging, but requires active management. The primary risk remains volatility decay and timing sensitivity in a market where tech stocks have shown long-term growth trends.

UnitedHealth Group Inc

UnitedHealth Group (UNH) trades at $370.95, down 1.34% on the day, amid a bearish technical signal from moving averages. The company reported strong Q2 2026 earnings, beating estimates with EPS of $6.38 versus $4.91 expected, and raised full-year guidance. Revenue for 2025 reached $447.57 billion, though net income margin declined to 2.69%. Analyst consensus remains strongly bullish with an 82.69% buy rating and a $470.11 price target, suggesting significant upside from current levels.

UNH presents a compelling investment case driven by earnings beats, raised 2026 outlook, and strategic initiatives like AI investment in Optum. Key risks include regulatory pressures in healthcare, volatility from Medicare Advantage plan changes, and margin compression. The stock's valuation at a P/E of 23.84 appears reasonable given growth prospects, but investors should weigh execution risks against the positive analyst sentiment and institutional backing.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

SQQQ
98% Buy2% Sell
Avg holding period · 12 Days
UNH
71% Buy29% Sell
Avg holding period · 97 Days

Top news

Latest headlines on both assets

About ProShares UltraPro Short QQQ ETF

SQQQ is a leveraged inverse ETF that seeks daily investment results, before fees and expenses, that correspond to three times the inverse (-3x) of the daily performance of the Nasdaq-100 Index. It is a tactical trading tool designed for sophisticated investors to profit from or hedge against declines in large-cap technology and growth stocks. Due to its daily reset and the effects of compounding, it is intended for short-term use and carries significant risk if held during periods of high market volatility.

Read more on SQQQ →

About UnitedHealth Group Inc

UnitedHealth Group is one of the largest private health insurers, providing medical benefits to 50 million members globally, including 5 million outside the U.S. at the end of 2021. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in managed care. Along with its insurance assets, UnitedHealth's continued investments in its Optum franchises have created a healthcare services colossus that spans everything from medical and pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.

Read more on UNH →